Caution, this is an AI generated summary based on literature. This may have errors, see here for more.
Please share your feedback with us.
MIR218-2: MIR218-2 is a microRNA encoded within an intron of the SLIT3 gene [PMC5909645]. It is involved in neuron differentiation [PMC3020728]. In the cortex of Alzheimer's disease (AD) patients, MIR218-2 is upregulated [PMC7564652]. MIR218-2 has not been previously studied or reported in the brain tissue of AD patients [PMC7564652]. MIR218-2 targets Tau and its phosphorylation, as well as secretases [PMC7564652]. In Parkinson's disease (PD) patients, MIR218-2 is notably down-regulated [PMC5288660]. Overexpression of the Wnt signaling pathway increases the levels of MIR218-2 [PMC4748271]. The variant rs11134527, located outside the MIR218-2 hairpin sequence, significantly changes the expression of miR-218-5p [PMC4439572]. In kidney and prostate cancers, several dysregulated microRNAs including MIR218-1 and MIR218-2 are involved in targeting CUL3 gene expression [PMC2683874].
MIR218-1 is another microRNA encoded within an intron, specifically within the SLIT2 gene [PMC2683874]. It has been found to be downregulated in AD patients' cortex [PMC7564652]. Other dysregulated microRNAs in AD include MIR129-2, MIR1296, MIR219A1, MIR29B1, MIR375, MIR411, and MIR431 [PMC7564652]. On the other hand, upregulated microRNAs include: 199A2, 24-92A1, and 99A [PMC7564652]. These findings suggest a potential role for these dysregulated microRNAs in AD pathology [PMC7564652].
Genome locations
Gene Ontology annotations
Ancestor Chart
Loading ontology ancestors...
Failed to load QuickGO Ancestor chart
Sequence
Sequence features are shown above as colored rectangles.
Zoom in and click to view details, or
Reset